CBT for high anxiety sensitivity: alcohol outcomes

Addictive Behaviors
Janine V OlthuisSherry H Stewart

Abstract

High anxiety sensitivity (AS) has been associated with greater alcohol consumption and alcohol-related problems as well as greater sensitivity to the anxiety-reducing effects of alcohol and greater risky negative reinforcement motives for drinking. The present study reported on the alcohol-related outcomes of a telephone-delivered cognitive behavioral treatment (CBT) designed to reduce high AS. Eighty individuals with high AS (M age=36 years; 79% women; 76% Caucasian) seeking treatment for their AS-related concerns participated in the study and were randomly assigned to an eight week telephone CBT program or a waiting list control. Participants completed measures of drinking motives and problem drinking at pre- and post-treatment. Multilevel modeling showed that the treatment was successful in reducing AS. The treatment also resulted in specific reductions in drinking to cope with anxiety motives as well as physical alcohol-related problems. Mediated moderation analyses showed treatment-related changes in AS mediated changes in drinking to cope with anxiety motives. Changes in drinking to cope with anxiety motives mediated changes in physical alcohol-related problems. Results of the present study suggest that an AS-targeted int...Continue Reading

References

Sep 22, 2000·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·P J ConrodM Dongier
Dec 5, 2000·Alcoholism, Clinical and Experimental Research·A B MacDonaldM Skinner
Sep 25, 2003·Alcoholism, Clinical and Experimental Research·Richard FeinnHenry R Kranzler
Feb 14, 2007·Alcoholism, Clinical and Experimental Research·Martin ZackColin M MacLeod
Feb 20, 2007·Behavior Modification·Norman B SchmidtMeghan E Keough
Apr 25, 2007·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Michael J ZvolenskyMatthew T Feldner
Jun 15, 2007·Psychological Assessment·Steven TaylorSamuel Jurado Cardenas
Jul 26, 2008·Annual Review of Psychology·John W Graham
Nov 4, 2009·Psychological Bulletin·Bunmi O Olatunji, Kate B Wolitzky-Taylor
Nov 16, 2010·Clinical Psychology Review·Kelly S DeMartini, Kate B Carey
Jun 8, 2011·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Kirsten A JohnsonMichael J Zvolensky
Jun 10, 2014·Journal of Consulting and Clinical Psychology·Janine V OlthuisSherry H Stewart

❮ Previous
Next ❯

Citations

Jun 14, 2016·American Journal of Preventive Medicine·Claudia Trudel-FitzgeraldLaura D Kubzansky
Oct 26, 2016·Clinical Psychology Review·Michael W OttoStacey N Doan
Jun 9, 2017·Journal of Psychoactive Drugs·Blaise L WordenDavid F Tolin
Mar 25, 2018·Alcoholism, Clinical and Experimental Research·Ashley M EbbertRobert F Leeman
Dec 3, 2016·Current Addiction Reports·Patricia J Conrod
Jun 29, 2021·International Journal of Cognitive Therapy·Juliana M B KhouryKim MacLean
Jul 3, 2021·Journal of Substance Abuse Treatment·Blake T HiltonR Kathryn McHugh
Jul 10, 2021·Alcoholism, Clinical and Experimental Research·Erin C BerenzRachel Ranney
Aug 3, 2021·Addiction·Emma CorcoranGlyn Lewis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.